Q4 2019 Earnings Call
After the speakers presentation, there will be a question and answer session. Just a question during especially the press star one on your telephone. Please be advised todays conference is being recorded if you require any further assistance. Please press Star then zero I would now like to Dystrophies forums comps definitely roster maybe getting them.
Thank you cabin.
Good morning, welcome to agree on fourth quarter and full year 2019 earnings call.
Definitely Willis Vice President Investor Relations and corporate Communications Officer.
To be with you today I look forward to working with all of you in the month two years to calm as we've discussed ingredients performance.
Here with me today, or Jim Valley, or President and CEO, and Jim Gray, our executive Vice President and Chief Financial Officer.
Our results were issued this morning in a press release that can be found on our website ingredion dot com and the Investor section. The slides accompanying this presentation can also be found on the website and were posted a few hours ago for your convenience.
As a reminder, or comments with in this presentation may contain forward looking statements.
These statements are subject to various risk and uncertainties.
Actual results could differ materially from those predicted in the forward looking statements and ingredient is under no obligation to update them in the future as far as circumstances change.
Additional information concerning factors that could cause actual results could differ materially from those discussed on today's conference call or in this mornings press release can be found in the company's most recently filed annual report on form 10-K, and subsequent reports on forms 10-Q, an 8-K.
During this call. We also refer to certain non-GAAP financial measures, including adjusted earnings per share adjusted operating income adjusted effective tax rate and adjusted cash flow from operations, which are reconciled to U.S. GAAP measures and no to non-GAAP information included in our press release and in todays presentation appendix.
And with that I'm pleased to turn the call over to Jim's Alley.
Thank you Tiffany and welcome to everyone joining us today.
In 2019, we made excellent progress executing on the four pillars supporting our strategy in a rapidly changing food and beverage industry.
Our strategic investments aligned with consumer preferences and trends.
And our strong relationships with customers are creating exciting new opportunities.
Across the specialties portfolio, we are building and expanding.
And with the improvements in operating efficiency and the delivery of cost savings, we've created a more agile organization.
We are advancing growth initiatives in each of our platforms and at the same time, we continue to take actions to address and mitigate macroeconomic challenges.
Let me turn to our fourth quarter results.
For the quarter global net sales delivered modest growth absent $55 million of negative foreign exchange impacts net sales were up 4% versus the prior year.
Adjusted operating income for the quarter was down 5% year over year, However, up 1% absent foreign exchange translation impacts.
For the full year, our global net sales were down 1%.
Absent $292 million of negative foreign currency impacts net sales were up 4% versus the prior year.
Adjusted operating income was down 8% versus prior year and down 2% absent foreign exchange translation impacts.
This year, we progressed are driving growth roadmap by advancing on trend specialty growth platforms.
Our specialties portfolio now represents 30% of our total net sales.
Specialty growth was led primarily by starch based texturizers as well as sugar reduction and specialty sweeteners.
Starch based Texturizers delivered low single digit net sales growth driven by contributions from our tapioca at potato starch portfolios as well as the acquisition and integration of Western Palmer.
As for our sugar reduction and specialty sweetener platform, we delivered high single digit net sales growth during the quarter driven by greater consumer demand for non GMO sweeteners and sugar reduction ingredients.
In November we opened our al you lose facility in Mexico and have already generated our first cellulose sales.
Throughout 2019, we made significant investments in plant based proteins to meet growing customer demand.
We are now well position to capitalize on this opportunity and are on schedule for 2020 production.
We are leveraging our broad an ingredient portfolio and formulation capabilities to advance our approach to customer co creation.
We've now operationalize design thinking and speed to market principles to accelerate the innovation process and are engaged with select customers, who most value this close form of collaboration.
Throughout the year, our team did a tremendous job streamlining our organization and redefining the way we work.
We achieved significant improvements in operational efficiencies and delivered nearly $75 million of run rate savings well in excess of where $30 million to $40 million cost smart savings target for 2019.
We have broadened and accelerated our transformation efforts and as a result are increasing our three year savings target to $150 million by 2021.
Now, let's move to discuss the highlights of each regions performance.
In North America sales were up slightly for the quarter versus prior year.
Favorable price mix offset the plan stopped in volume shed of high fructose corn syrup and industrial starch.
Operating income was $113 billion down 1% year over year.
Improved price mix versus the prior year and cost smart savings benefits were more than offset by higher core costs.
For the year sales were down slightly primarily due to the plan stuff in volume shed, which was partially offset by favorable price mix and specialties growth.
Operating income was $522 million down 4% for the year.
The region faced higher net corn cost as a result of depressed coproduct values and a late harvest.
In 2019, we added western polymer.
Expanding our specialty potato starch manufacturing capacity and broadening our customer base.
Which is at the heart of our growth strategy in North America.
Turning to South America, we had very strong performance in the region with sales up 7% during the quarter.
This was led by strong price mix and volume growth across the region, partially offset by foreign currency weakness.
We are particularly pleased that this is south America's second consecutive quarter of profitable growth up 13% in the fourth quarter.
This improvement was driven by favorable pricing actions in Argentina and higher volumes.
Also as part of course, Smart, we began implementation of a transformational reorganization, which delivered benefits in the quarter.
And I'm very proud of our team in South America as they have effectively managed and continue to navigate a volatile business environment.
For the year, South America sales were down 3%.
The region experienced 200 million of foreign currency weakness.
Partially offset by $151 million of pricing actions.
South America operating income was down 3% for the year.
Foreign exchange impacts and higher corn costs were partially offset by pricing.
Specialties volume growth and cost smart savings.
In Asia Pacific sales for the quarter were down 4% due to unfavorable price mix.
Operating income was down $7 million, partially driven by increased core costs in Australia.
Asia Pacific results were also pressured by the continued macroeconomic weakness across northern Asia.
For the year sales were down 2% due to unfavorable currency impacts primarily in Korea.
Operating income was down $17 billion for the year, driven by weakness across northern Asian economies, which were impacted by trade disputes and higher input costs. We also experienced increased corn costs in Australia.
As part of cost Smart, which includes network optimization, we made the decision to close our Linco facility in Australia.
The persistent corn cost increases from water scarcity.
We expect to realize input cost benefits over the next three years.
I'd like to pause for a moment and share that we're monitoring developments and impact to date of the Corona virus.
First and foremost we've taken actions to minimize the risk to our employees in China and across the region as well as address business continuity concerns for our customers.
We were not impacted financially in the quarter and it is premature to speculate on the extent of the 2020 impact.
We remain close to the situation as we keep our employees health and safety and our customers needs top of mind.
Moving to EMEA, our sales were slightly down for the quarter absent foreign exchange impacts, which occurred primarily in Europe net sales for the region were up 7%.
Operating income was down $2 million driven by higher input costs, primarily in Europe.
For the year net sales were down 2%, primarily driven by foreign currency weakness in Pakistan.
Operating income was down $17 billion for the year, driven by higher corn costs and foreign exchange impacts in both Pakistan and Europe.
In Pakistan the team worked hard to largely mitigate the weakness in the rupee through strong pricing actions.
Now, let me turn it over to Jim Gray, who will review the financial results in more detail.
Thank you Jim.
Net sales of $1.549 billion were up 1% for the quarter versus prior year.
Gross profit margin was flat as favorable price mix offset higher input costs and foreign exchange impacts.
Reported and adjusted operating incomes were $170 million and $168 million respectively.
Reported operating income was slightly higher resulting from a $22 million benefit from indirect tax credits recorded in Brazil.
Partially offset by 16 million of restructuring charges associated with cost smart and 4 million of integration and other costs.
Our reported an adjusted earnings per share were both $1.61 cents.
Fourth quarter net sales of 1.549 billion was up 1% versus prior year unfavorable FX at $56 million was primarily attributable to were weaker currency devaluations.
Volume was flat, while favorable price mix accounted for $68 million of net sales increase.
In North America, net sales were up slightly versus prior year price mix was up 3% as a result of product mix and price pass through of higher corn costs.
This was partially offset by volume shed as we see sweat milling and our Stockton facility in November 2018.
In South America, net sales were up 7% with volume up 9% across the region.
Price mix was up 16% as our teams took price increases to recapture the foreign exchange impacts felt in Argentina, Brazil and Colombia.
APAC net sales declined 4% due to lower sales primarily in our siani as customers benefited from a pass through of lower Tapioca route cost.
EMEA net sales declined 1% due to foreign exchange impacts, partially offset by favorable pricing actions in Pakistan.
For the quarter reported adjusted operating incomes increased $12 million and decreased $9 million respectively.
The decrease in adjusted operating income was primarily due to Asia Pacific factors that Jim as previously highlighted.
Corporate costs increased by $3 million versus the prior year due to lapping of adjustments and continued investments to drive innovation and streamline global processes.
I'll wrap up fourth quarter with a discussion of our earnings bridge.
On the left side of the page you can see the reconciliation from reported to adjusted.
On the Rightside operationally, we saw a decrease of 10 cents per share for the quarter.
Driven by foreign exchange impacts.
Other income.
Margin of a negative 12 cents negative six cents negative three cents per share respectively.
Volume improvements had a positive contribution of 11 cents per share.
Moving to our non operational items, we saw an increase of 10 cents per share for the quarter driven by lower tax rate lower average shares outstanding which contributed a benefit of seven cents per share and four cents per share respectively.
Turning to our full year results, we delivered $6.2 billion of net sales, which was slightly down versus prior year.
Reported and adjusted operating incomes were $664 million and $705 million respectively.
Reported operating income was lower than adjusted operating income by $41 million.
As $57 million and restructuring charges related to cost more and $6 million of integration and other costs or partners, partially offset by 22 million dollar benefit from indirect tax credits recorded in Brazil.
Our reported and adjusted earnings per share was $6.13 $6.65 respectively.
As just mentioned for Internet sales of $6.2 billion was slightly down.
They were both foreign exchange of $292 million was partially offset by favorable price mix of $264 million.
Line was slightly down due to plant Stockton volume shift.
In North America, net sales were down slightly versus prior year as a result of plan stocks and shed.
Which was partially offset by price mix.
In South America, and net sales were down 3% due to unfavorable foreign currency impacts, which were partially offset by price mix increases of 15% and volume increases of 2%.
APAC net sales declined 2% due to foreign exchange.
Volume and price mix remained flat.
EMEA net sales declined 2% driven by foreign exchange impacts primarily in Pakistan.
Partially offset by price mix increases of 7% and volume growth of 2%.
Full year reported and adjusted operating incomes were 664 million in $705 million decrease of $39 million and a decrease of $62 million respectively.
South America operating income decreased slightly versus prior year and the region overcame significant first half foreign exchange impacts and demonstrating strong price mix and volume in the second half.
North America operating income was challenged primarily by higher net corn costs throughout the year.
Asia Pacific operating income was down 16% versus prior year as the reason face weakness across northern Asian economies impacted by trade disputes and higher corn costs in the region higher operating costs in Australia.
EMEA operating income performance was primarily impacted by challenging business conditions in Europe.
Higher corn costs and foreign currency weakness, we're the largest drivers.
Now, we'll shift to the full year EPS bridge.
On the left side of the page you can see the Rick reconciliation from reported to adjusted.
On the Rightside operationally, we saw a decrease of 65 cents per share for the full year driven by foreign exchange impacts margin and other income of negative 49 cents 25 cents and 10 cents per share respectively.
Some improvements had a favorable impact and 19 cents per share.
Moving to our non operational items, we saw an increase of 38 cents per share for the full year.
Primarily driven by lower average shares outstanding which contributed a benefit of 41 cents per share.
Our financing costs, our net result of a benefit from favorable lap of exchange losses from the prior year.
Partially offset by current year increase in hyper inflation adjustments of 10 cents per share.
Moving to cash flow 2019 cash provided by operations was 680 million.
Capital expenditures were $328 million down $22 million from the prior year.
Our full year 2019 capital commitments were $347 million as we continue to invest in our growth platforms.
Acquisitions, and investments were $52 million, reflecting investments in western polymer and other ventures.
And we have returned $174 million and dividends to investors.
Turning to our income statement outlook.
We anticipate 2020 adjusted earnings per share in the range of $6.60 to $7.20.
This excludes acquisition related integration and restructuring costs as well as any potential impairment costs.
We expect net sales and adjusted operating income to be up versus last year.
We anticipate foreign exchange impact to be negative in 2020.
With unfavorable impact of negative 10 cents to negative 20 cents per share.
Corporate expenses are expected to be up 15% to 20% year over year, partially due to the centralization of regional costs to support center led growth initiatives and technology investments.
We anticipate increasing our cumulative end of year run rate cost smart savings from 74 million in 2019 to 90 million to 100 million.
At the end of 2020.
Financing costs for 2020 are expected to be in the range of 80 million to $85 million.
This includes an expectation of more than a $10 million negative impact due to hyperinflation.
Our adjusted effective annual tax rate is expected to be 26% to 27%.
We are assuming total diluted weighted average shares outstanding to be in the range of 67 to 68 million for the year.
In North America, 2020, net sales and operating incomes are expected to be up supported by specialty volume growth.
Sales momentum builds for plant based proteins and outflows.
We also expect a favorable impact from cost smart savings.
Moving to South America full year net sales and adjusted operating income are expected to be up volumes are expected to be up.
Asia Pacific net sales are expected to be up and operating income is expected to be modestly up.
As we mentioned we're closely monitoring the impact of the Corona virus and will provide an update in our first quarter call.
EMEA net sales are expected to be up and operating income is expected to be modestly up.
We expect cash from operations to be in the range of 640 million to $710 million.
We also expect to invest between $285 million at $305 million and capital expenditures as we continue to invest in our specialty growth platforms.
In closing, we continued making investments to grow our specialty platforms, while further optimizing our core business, which produced more stable results. This year, despite an even greater foreign exchange impact.
We continue to generate substantial cash from our operations and remain committed to returning value to shareholders.
That let me hand back to Jeff.
Thanks, Jim.
2019 was a year in which we made meaningful progress positioning the company for improved performance and profitability.
We advance the five growth platforms in our driving growth roadmap.
And continue to increase the share of our specialty net sales as a percentage of our total portfolio.
Across our markets, our specialty investments are aligned with consumer trends and our strong relationships with customers are creating new opportunities and greater demand further positioning us for growth.
We could not have achieved this without the hard work commitment and focus of our 11000 employees around the world who bring their best to the company each and every day.
For the 11th consecutive year, we were recognized by Fortune magazine as one of the world's most admired companies.
We're also proud to have been included in Bloomberg's gender equality index for the third consecutive year.
These distinctions are a testament to our purpose driven culture of bringing together the potential of people nature and technology to make life better.
We will be presenting a cagney next week on February 18th and we look forward to discussing our driving growth agenda in more detail.
Thank you and now let's open the call for questions.
Ladies and gentlemen, if you have a question recombinant. This time. Please press Star then one key on your touched on telephone. If your question has been is reduced to result from the Q. Please press the pound Keith.
Our first question comes from Ben be Avenue with Stephens, Inc.
Hi, Thanks, good morning.
Hey, Ben Good morning, but I'm wondering I wanted to start asking about kind of a tough ones I know it's open ended in a moving target, but current environment. If you could talk about.
You have seen to the extent you've seen anything so far in one Q, whether it's in the demand destruction or logistical challenges that are impacting costs.
Directly on your business and then indirectly obviously, we've seen the impact on soybean meal in soybean oil prices, which impact your opponent value, but if you could just talk about.
As it stands right now.
What the direct and indirect impacts or on your business as it relates to prune matters.
So Jim let me take that and you can add any commentary. So first of all we have to manufacturing facilities in China.
Both of those facilities are respectively about 850 kilometers from.
In different provinces.
The.
Impact so far that we have seen is like most companies a delay mandated by the government.
For employees that went away for Chinese new year to return back.
And then in some cases some mixed signals around.
Quarantine time periods that being said.
One of our factories has been operating uninterrupted.
The other factory.
Has been operating one line only with a abbreviated staff.
And.
It has been delayed and its production by approximately two weeks.
All of our employees are safe.
None of our employees, thus far that we know of contracted Perona virus and the office has a protocol in place in regards to.
How to operate the sales office.
Which has been operating each and every day.
With with reduced staff, Jim as far as the impact you want to make take that.
Right now, it's it's I think it's hard to suspend hard to speculate because.
Really we just have a delay in some of our people coming back to work.
We have sufficient inventories.
It's really about what the delay in the demand for shipping might turn out to be.
And Thats really what have we kind of we just have to see kind of every two weeks how it plays out throughout Q1, there clearly will be a slowdown in demand from our customers as well as their operations are equally impacted and I think that thats something that we anticipate.
Yet.
At this point cannot quantify.
So we're monitoring the situation, obviously very closely and depending on how long this situation drags on.
The impacts to the supply chain down down the road in the future.
There is something that we have to watch in the near term, we have ample inventory for customers and again one of our factories is operating.
Unrestricted.
And the other one line is operating and the other line.
Should be operating here.
By the end of this week actually.
And then maybe in the second part of your question was.
So you DC soybean.
Man backing up.
And in weather what are the ramifications on some of the co products that we sell.
I think if you witnessed over the last.
Among the two months.
At least soybean oil corn oil.
Palm oil have all been significantly up due to some constraints in those marketplaces.
And so and we've seen some softening.
Corn meal prices.
Again, we're Skinner, we're going to watch.
How much anticipated demand I think.
And backup on soy.
And whether or not that theres decisions to crush that and whether or not that impacts.
Availability of both soy meal as well soil.
Right now it seems like a lot of the crushing is going towards kind of to Bruce more soil because that's the better part of.
The arbitrage.
Fair enough and and as it relates to the guidance.
You have a wider range you guys gave a wide range last year is that uncertainty around corona virus contemplated in the guidance at all as we look towards the lower end of the guidance range.
And then one more question on guidance just generally your outlook for net corn costs Thats incorporated into the guidance for 2020.
Yes sure.
So I think with our guidance when we were obviously us assembling that and.
And pulling that together Corona was not was not kind of a factor on the horizon. So so generally does not include.
Any kind of.
Significant or delayed impacts if those will even materialize Jen mentioned were up and running at one of our facilities and the other facility has.
At least one production line running.
With regard to more of our outlook for.
Coproduct values as it relates to the our cost of corn.
And I assume that the scope of that was really kind of more around North America Us Canada.
When we pull together our estimates we're really doing that kind of more back in December.
In November December when those price.
Prices are in place, we see the run up in some other coproduct values very recently.
We're waiting to see if those have a kind of.
An enduring longevity.
Throughout the year.
So thats really not.
Our guidance really on the co products is really more of kind of based on what we might see is kind of more than three year average during the fourth quarter.
Okay perfect. Thanks best of luck.
I do think it's important to point out regarding China that it's between two and a half a percent of our sales overall as a company. So just to help put in perspective.
Perfect. Thanks, guys.
Sure.
Our next question comes from Heather Jones with how the drones research.
Good morning, Thanks the question.
Just a follow up on Dan's questions I just wanted to.
Condense, what you guys said so.
There's no impact from Corona virus built into your guidance you pull that together.
Prior to that becoming a bigger factor.
You would need to spillover.
Given the size relative size of China to your business, we will need to see the spillover impact into.
Europe, South America et cetera for to be meaningfully your opinion am I understanding your commentary correctly.
I think given the fact that.
We are having the call today, and we finalized everything and prep for this call.
That.
Doesn't as Jim said.
Take into account any significant or meaningful impact.
Of Corona virus, but it does take into account what we know as we sit here today.
As we have provided guidance, which does take into effect some impact as I. Just described in relationship to our operations for example, so.
That's what I would say about.
How we view grown a virus and again.
China is about 2% to 2.5% of our overall sales as a company so.
And we hopefully that that helps with.
The answer.
It's just too early right now to fully assessed.
The total impact.
That is helpful.
North America, which is obviously the big driver.
Business.
Was wondering if you could give us a sense of the visibility you have into your guidance. There you mentioned that.
Well my take away from your comments was that your guidance Doesnt give effect to the recent.
Very recent Ron we seen in veg oil prices, but more like a Q4 average.
What.
Could yield upside and downside risk to your North American business based upon what you know about.
Wrapping season, what you know about your.
Corn costs can you just highlight the biggest risk upside or downside to that North American outlook.
Sure well, let me start and then I'll, let Jim make some comments. So first of all we're seeing low single digit average price increases across North America and flat to low single digit change in the cost of core.
And thus margins are flat to slightly expansive.
We expect high fructose corn syrup sweetener volumes to be down in line with their historical.
Norm of trending down.
Between one and 2%.
Flat to slightly positive volume growth across the rest of the North America business and continued mid single digit volume growth for specialties.
We anticipate that corn basis, we'll continue to be elevated during the first half of the year until expectations for the new new corn crop emerge and clearly as it relates to risks we're assuming.
A return to an average corn crop with normal planting on time planting et cetera.
I would say volumes are always a risk in north America to our business.
But were.
Right now assuming taking into account what I just talked about in relationship to the.
To the volume trends that we're seeing.
So Jim I'm going to turn it over to you don't have any additional color commentary, perhaps on co products were coproduct recoveries, yes, I mean, I think as we thought about that.
You were expecting very modest coproduct values recoveries.
As we do not see any trade flows between us and China resuming with any kind of positive effect quickly throughout the year.
Okay.
And I, just I don't want to labor that point, but I just want to see what you guys are seeing versus what I may be seen.
And you made the point that.
Corn meal values have traded down some but there's been.
Very sizable rally and.
Thank you all value and so.
Looking at cash corn, which does have some elevated basis relative to cash byproduct values.
Pretty nice recovery in that rate recovery from Khalid early Q4 to the president.
Is there something that is limiting you guys from seeing that or you just being conservative and assuming that may not continue for the rest of year.
I understand how youre thinking about it.
Well I think.
Obviously, there's.
12 months in the year and just the necessarily the January rise in two of the values Doesnt make.
For the full year forecast.
Part of the run up in corn oil has been due to a little bit of constrained constrained supply. So I think of that has potentially some temporal effect to it.
At least in the us.
You'll meal prices are have come up but there is an abundance.
We'll see at least of soy meal in the marketplace and so we're kind of where measured and our outlook for that value and feed values, usually follow corn. So corn has been trading in a pretty tight range.
With with regard to kind of the outlook for the layout a corn for 2020.
So we're not we don't see necessarily something where we see all of the co product values all rising because of continued tightness in the market.
Our higher demand.
So we're just like you know as I said, we expect kind of modest co product value recoveries.
Because we just don't see a lot of the big moves yet from from demand pull in from China.
Right.
Okay and my final question is just wondering if you could give us your updated thoughts on what you're seeing in the Brazilian economy.
Yes.
The currency has been incredibly weak leave at that.
Could be attributable to just the risk of attitude and all but like what are you seeing on the ground floors.
Trends there.
Yes.
Comments, so for for South America in General I mean, we expect low single digit volume growth in Brazil and.
And basically on the ground there.
We are seeing very strong specialties growth, we highlighted that for quarter four and so.
We're seeing a lot of activity by customers that are.
Formulating very much on trend.
Ingredients on trend within on trend ingredients that we supply.
Cater to the latest trends and so we're seeing I guess I would say strong.
Economic activity or a pickup in economic activity in in Brazil, and so we expect operating income to be up in the region, primarily driven by Brazil volumes and lower net core costs.
As well as benefits of cost more across the region.
Okay perfect Thats very helpful. Thank you.
Thanks Heather.
Our next question comes from Britain, only with Seaport global.
Hey, good morning, guys. Thanks for taking my questions.
My questions are going to focus on the specialty part of your portfolio.
Valley I think you said in your prepared remarks that.
During Q4 texture grew low single digits. Thanks for thanks for those comments by the way.
If that is the case I thought texture.
Might be growing a little bit more than that and so I just wanted to revisit that comment with you and see if there was anything during the period that might have have weighed on that and just get your continued outlook for texture specifically.
Yes, no I don't think there's anything weighing on a per se I think that.
Textured will be made up by our starch based texture riser portfolio, our clean and simple ingredients.
And our approach to customer co creation and food systems. So all of those.
Customer engagements continue to go very well and one of our areas of focus is to diversify beyond corn.
And so we really are seeing growth in our tapioca franchise as well as our potato starch franchise and I'm also pleased to say one of the things we didnt really highlight explicitly in the prepared comments was that our rice investment in Thailand will also be commissioning in quarter. Two of this year. So those are all very.
Three strategic purposeful investments to diversify.
Beyond corn.
Which is the main staple but with trends towards grain free for example, we see.
In increased demand for those ingredients and they also provide different functionality supplementaries functionalities for products like snacks, and snacking, which is growing and so.
We feel very good about our to our starch based texturizers portfolio as well as the Hydrocolloids that we have now in our portfolio to complement starch based and then we're very excited obviously by what protein is going to offer also.
As it relates as it relates to rounding out texture. Additionally, with protein fortification as well.
Okay, Thanks for that and staying on the topic of texture.
We've talked to some other.
Sorry, we've talked to some other you know what I call adjacent.
Ingredient appears of yours.
And it does sound like more participants are interested in entering or expanding on their extra capabilities and I'm not necessarily asking this question from a competitive threats standpoint, but but I am interested in understanding if you believe.
The texture capabilities are becoming more sought after.
But by the broader ingredients space as a whole.
So I think that.
One of the things that the.
As an ingredient supplier you want to be in a position to do is via problem solver and to do that with speed and so.
Next year.
He is one of the most important.
Qualities and attributes for the overall since oreal experience of a food product and so.
We feel very good about who we are in that space of texture being the broadest and deepest in the world of specialty starches and in addition, having now capabilities in Hydrocolloids as well with a very purpose will focus on customer co creation, which is all about.
Working with select customers in a very.
Concentrated time period.
To go from concept.
Two.
To the to the shelf and we are.
Being perceived as a more complete.
Formulation and solutions provider in that regard and so texture, we'll continue to be a hallmark of our.
Of our value proposition that we bring to customers.
Thank you for that and then just one more on specialty. This this has more of a regional focus but.
We aim to derive your regional specialty performance based in part on core in specialty performance from some of your peers, but we back into strong specialty performance for ingredient in Latin America similar to what you announced this morning.
We also back into solid growth.
Our performance in Asia and Europe.
In North America more recently, we're we're backing into like low single digit growth for your specialty and I wanted you to weigh in on whether we're in the right ballpark, there and whether or not you can go into some detail in described the state of your specialty portfolio in North America today.
And how these dynamics might change in coming periods as you place investment.
In adjacent areas. Thank you.
So.
Just going back to a comment I made earlier.
We.
Indicated that for North America, we're seeing continued mid single digit volume growth for specialties in our guidance.
As it relates to North America, one of the things. We're most excited about is our new plant based protein capacity expansion.
And commissioning of the facility in Nebraska, which will be available in the second half of the year and we expect to see incremental net sales and contributions beginning to cover the startup cost of that facility.
In the second half of this year.
We're seeing very strong customer interest in customer engagement as this new ingredient platform.
You know.
Comes to market and so we're very excited about the specialties prospects for.
Pulse protein isolates as well as flowers and concentrates and again the complimenting complementing formulation capabilities that provides to our customers in North America.
I mean, I'd also add that within North America is our largest specialty book of business.
As well as you we haven't talked much charts foods systems.
The data in of itself just how how we look at comes as a growing part of that business as well as sugar reduction. We also had a very strong quarter in Mexico for specialties growth, which is included in our North America business. So if that gives you even a little bit more color in relationship to overall North American specialties.
That's great. Thank you guys.
Thank you.
Our next question comes from Conns ESMO Bank of Montreal.
Hey, good morning, guys.
Okay.
A couple questions what is last quarter. Your FX was aligned with your price, replacing them say more aligned with your FX and you offset more this will it seemed to be a widening spread I would've thought that then it would have been continued narrow can you talk about at what point do you expect pricing to overtake the FX.
Headwinds and how do you think about that.
Well this I mean this quarter.
A highlight price mix was.
In Q4 was 68 million to the positive FX was was.
Headwind of 56 million.
So we did see some price mix in Q4.
That was greater than the FX headwinds I think what you're seeing is that.
In South America, we're seeing.
Local inflation and pricing kind of ahead of that.
Which is which is catching up with that with that past FX weakness.
Where you had some some newer.
I think some some newer FX softening would have been in some of the Asia Pac countries.
And as we noted can try and too.
Gain back price on weakness in the Korean won is challenging on that will take time as as one example.
Okay actually I'm, sorry, I actually in North America, but okay, but do you think that there will be a plene time that the.
Excluding North America the.
FX or the pricing will more than it also because history has shown that that's what you do something I just want to make sure that things have not changed or do you think things have gotten a little bit more complicated with South Korea.
As well as the EU that maybe not see that as much but that is what I would expect overtook.
Yes, let me, let me just take that and again I just want to draw you back to my comments.
South America really.
Represented the biggest challenge for us as it relates to pricing.
To offset foreign currency weakness and I want to remind you that region experienced $200 million of foreign currency weakness in the year, which was offset by $151 million of pricing actions now one of the things that I think we all observed is the steep devaluation of the Argentine.
Peso, so we have been and catch up mode.
There, but I also called out the efforts of our team who have done a fantastic job of moving price there and we are seeing very good progress in relationship to their pricing actions to offset that just when we thought the Brazilian reigh.
Based on everything you.
Read and are observing in relationship to the economy, and political stability and pension reform and fiscal reform getting past yet.
We have been somewhat surprised to see some continued weakness in the reigh. So again.
Pricing is the lever that we pull and we are confident that we're going to continue to make progress.
In South America, and I call L., South America, because again it represented 200 of at 292 million in the year and I think our team has done actually a very very good job the problem is.
It's been unabated.
In relationship to the foreign exchange headwinds that we faced and in fact.
Tim called out I believe in our guidance.
That we anticipate foreign exchange weakness, which is factored into our guidance of an additional $30 million to $50 million of.
No format.
To the impact of net sales yes.
So hopefully that helps Ken.
As it does.
This second question I have is when I'm thinking about your capital projects. That's a little light on 2020 can you talk about the incremental EBITDA thats associated with that.
That we can think about in 2020 in 2021 and beyond how do we think about that.
Yes, sure if you could take that yes, so ken as.
Jim had mentioned.
That let's take plant based proteins in North America as an example.
So were.
Completing the production lines right now we're running.
Product through and were commissioning.
That commissioning.
Timetable contain.
Six months three months six months, there's at least.
A period in there, where we have product that doesn't need to be approved by various government regulatory.
Agencies.
Then also customers are doing their own kind of audits.
Plants and other product quality.
So right now we have a full costs.
Running those was running on our south to city facility.
We will hit RPL and 2020, we'll start to see sales more than second half and the contribution from those sales will start to.
Contribute to the incremental EBITDA that your questions. So right now it's actually a cost impact to the PNM now when we're in the commissioning mode.
As we move more towards 2021.
And sales build as we as we move through the end filled to capacity then we will see the contribution margins offset so we get kind of a swing impact on the PNM of a more towards 2021, yeah I would say just to answer it in kind of totality. It's certainly plant based proteins is a major investment for us, but there is the iOS investor.
But there is the rice investment there are other investments that we've made across the global.
Specialties network, and I would say that because those investments or commissioning in quarter two for the most part.
We've been pretty modest I guess in our EBITDA contribution in calendar year 2020, but certainly we expect.
Additional contribution significant contribution in 2021.
Yeah.
Into that as we would like.
Would you expect the we turn to invest capital North of 15, 20% or as it kind of deals would you expected to be just still modest.
And just trying to frame that.
Just one last question Im sorry, just yet.
As we I, we explained a lot of folks so when we add this capacity generally our capacity.
Takes anywhere as short as three years and as long as five years.
To fill so we're looking usually at a run rates or 20% than 40%, 60% of the capacity filling because we've added capacity ahead of market demand.
And our sales teams are working with customers to design in.
The highly functional product, that's coming off of our new capacity.
So we generally see kind of hitting an ROI C.
Or paybacks on these projects somewhere around your three.
Your for when we have between 60 and 80% of our capacity filled so that's pretty typical of kind of larger.
Capital investments that we're putting into expanded texturizers.
Portfolio I think in the case of plant based proteins that might be more brought that might be shortened.
In terms of that horizon.
It is just a point of clarification.
Somebody asked and I just didn't lose to these are the difference between the low end in the high end of the guidance what are the key factors leave it there.
Yes.
So I think the high end of the guidance.
Would be that we see still kind of modest volume, but we would see kind of continued co product strength right now as I said kind of the center cut of our guidance is that.
We really to see very modest co product value recoveries in North America.
Thanks.
The values of the coal price continue throughout the year.
Evidenced that I think that would lean a little bit more towards upside.
And our.
In our guidance I think.
We have.
A little bit more filling up the capacity in some of our specialty investments.
Faster than what weve than what the horizon I just described I think that would lend itself to upside.
And then.
We really are not.
Seen any kind of.
In South America with respect to Argentina.
Right now we have.
An assumption for a weakening Argentina peso.
As I mentioned, we have greater than $10 million.
Expected from hyperinflation accounting.
That that is lands in our financing costs since the revalue.
The.
That assets in Argentina into us dollars.
And so on or hyperinflation accounting that does impact us.
In our on our income statement. So right now we're seeing at least some weakening of the peso I think if the pace at the government to different actions that really really.
Collapse, the peso than we'd have that would be more downside risk.
And then Corona virus I guess on the downside also would be factored into the low end of the guidance yes.
I really appreciate it thank you guys.
Thank you.
Your next question comes from rubber must start with credit Suisse.
Yes.
Hi.
No more questions on the guidance.
I think in the first half of 2019, you had some weather related costs in North America.
Should set up a pretty easy comparison I would think for 2020, especially if your pricing is rolling through.
Rather quickly can you give us an estimate as to what those costs were in 19 and.
Is it fair to say therefore that your earnings growth in 2020 would be front half loaded.
Yes, I'll take a picture Hey, Rob.
In regard to North America.
When we when we did have a little bit of weather related it wasn't significant.
As much I think it was it was more because when we had some some some rail lines freezing in some delays in terms of putting product through and there was nothing.
Anywhere close to 2014 or some more significant in years.
You're correct in that it does set up for a slightly easier lab I.
I think more importantly, with regard to North America would have been.
Where the coproduct values were in kind of what the cost accord wise.
Relative to pricing so it looks like we as we anticipate 2020 slightly higher gross corn.
And basis, and Weve priced to really kind of capture that back we're really tenancy and margins really flat, maybe just slightly expansive.
In North America.
So I don't think its I don't think it's a significant.
A significant bump up.
In the first half OE was we will continue to see kind of.
And.
Modest modest growth in North America for the first half.
Okay.
And in sweeteners, you're you're expecting the normal 1% to 2% annual decline in demand.
I would argue that pricing power. This year was enabled by the fact that you do close down Stockton.
But if 1% to 2% declines persist how does that set up for for pricing going forward for 2021 2022.
Yes, how close are we to.
Stability right now in supply demand for sweeteners in North America industry wise, well. So first of all the decline that I referred to was specifically to HF not for total sweeteners as far as that.
Decline so.
I think that the actions that we took with Stockton has certainly tightened our network to very high capacity utilization. So we feel very good about where we're at for 2020.
It's obviously hard to predict what's going to happen going forward in 2021 and beyond.
Related to where.
Sweeteners have declined.
Over the last decade, and where that will go go go going forward. It's just hard to predict so I think we just feel very good about where we're at right now with our network and our capacity utilization based on the actions that we have taken.
A follow up one more time it I mean, I don't think Ingredion has provided a broader sweetener volume kind of growth estimate for the industry. We're I don't think internally either so I think Jeff is declining 1% to 2% is it fair.
I'll, just say that broader sweeteners or.
I don't know flat is better than that over the past several years. So we didn't know.
Yes, I think that I think that broader sweeteners as it relates to.
Glucose era for example are growing in line with GDP growth, maybe 1% to 2% per year.
Depending on the application.
Yes, maybe.
Lower it's right around it depends on pop growth and per capita.
Which country your end, but you definitely see glucose and you see.
Dextrose as sweeteners some of those lend themselves to kind of unique.
Segments in some of muscle lend themselves to kind of.
Building back.
There are some textural roles and so we do see those kind of anywhere flattish to slip modestly up depends on really which country or end.
Good that's helpful. Thank you okay.
Your next question comes from Adam seamlessly with Goldman Sachs.
Yes, thanks, good morning, everyone.
And so I grounds been covered I just had a few clarification questions around the guidance first.
The increase in corporate expense $15 million to $20 million are so how much of that is actual investment in the business versus earnings coming out of our costs coming out of.
The at the segments, if you break those two please.
Yes sure about.
I think thats about a third is.
Costs moving from segments into center.
About a third is.
Specific investments.
And enhancing digital and and driving some of our go to market efforts centrally.
Third as kind of merit, and and inflation and kind of bonus reset normal kind of wage costs comp change.
Okay. That's helpful and then in whether it's the total company or by region, specifically in North America. What are the assumed net cost smart kind of earnings contribution in 2020.
Yes, so right now, we're we're not necessarily going through and disclosing by region kind of where cost smart.
Savings are we have we do have targets, we have targets specifically for both the SGN any or the operating expense side as well as the cost of sales and.
Side, and obviously, what we're doing as each initiative each project has a bit of a life of its own.
In terms of.
Getting to the hypothesis from hypothesis to implementation to action and so we just want to be.
Thoughtful as we roll those out so.
Adam I'll choose to differ on on answering that question.
Okay, and then I guess last one just the guidance on cash cash flow from operations I mean, one you exceeded the cash from ops guidance for 20.
19.
But then if I look at the 2020 guidance, you're actually guiding cash from ops potentially down at the lower end.
Versus the net income guidance, which is functionally flat at the low end can you just bridge between the changes in net income.
And cash from ops.
Yes so.
Essentially it's in at the as we closed out 2019, I think we add some favorability and accounts payable, which then we were anticipating that accounts payable.
Would impact working capital too.
A greater degree.
As we look forward to 2020.
We're very much focused as a team on our working capital change.
And we see still a.
So.
We very much want to tighten working capital, but as we grow revenue we're going to have.
More obligations with customers in form of accounts receivable as well as inventories and so while that.
Change in working capital will be a.
A drain on cash from ops.
Because the topline is higher we're still trying to reduce the rate of that change.
And Thats.
Thats it thats whats impacting basically our guidance as we think about cash from ops.
Obviously, we are not reducing capital commitment year over year to though.
Highlight on call, yes, Okay, all right great. Thank you very much.
Okay.
I'm not showing any further questions at this time, let's turn the call back over to our hosts.
Okay, well I would like to thank you for your time today, and Jim and I hope to see many of you a cagney next week in Boca Raton, and with that that concludes our call today.
Thanks very much.
Ladies and gentlemen. This concludes todays presentation you may now disconnect have a wonderful there.
Yeah.